Skip to main content

Table 1 Results of statistical analyses of outcome data from RCTs that investigated food product labels

From: What do we know about the effects of exposure to ‘Low alcohol’ and equivalent product labelling on the amounts of alcohol, food and tobacco people select and consume? A systematic review

Outcome or subgroup

Independent comparisons

Total participants

Statistical method

Effect estimate: SMD (95% CI)

Test for overall effect or subgroup differences

Product selection (with or without purchase)

1

202

SMD (IV, Random, 95% CI)

0.31 (0.04 to 0.58)

N/A

Product consumption

5

680

SMD (IV, Random, 95% CI)

0.27 (−0.12 to 0.66)a

Z = 1.36, P = 0.17

 - Intervention label denotes absence (“Fat-free)

1

256

SMD (IV, Random, 95% CI)

0.42 (−0.08 to 0.91)

 

 - Intervention label denotes absolute amount (“Low-fat”)

4

424

SMD (IV, Random, 95% CI)

0.38 (−0.21 to 0.98)a

Chi2 = 5.15, df = 1, P = 0.02

 - Female participants only

2

343

SMD (IV, Random, 95% CI)

0.45 (−0.02 to 0.92)a

 

 - Male and female participants

3

337

SMD (IV, Random, 95% CI)

0.15 (−0.35 to 0.65)a

Chi2 = 0.75, df = 1, P = 0.39

 - Parallel group (between-subjects) design

3

344

SMD (IV, Random, 95% CI)

0.05 (−0.16 to 0.26)a

 

 - Crossover (within-subjects) design

2

336

SMD (IV, Random, 95% CI)

0.51 (0.29 to 0.72)a

Chi2 = 8.76, df = 1, P = 0.003

Intention to select or purchase product

0

0

N/A

Not estimable

N/A

Intention to consume product

0

0

N/A

Not estimable

N/A

Belief associated with product consumption

1

34

SMD (IV, Random, 95% CI)

−0.66 (−1.32 to 0.00)

N/A

1

34

SMD (IV, Random, 95% CI)

−0.14 (−0.79 to 0.51)

N/A

Product appeal

8

1013

SMD (IV, Random, 95% CI)

−0.01 (−0.14 to 0.13)a

Z = 0.09, P = 0.93.

 - Intervention label denotes absence (“Fat-free)

2

412

SMD (IV, Random, 95% CI)

−0.01 (−0.21 to 0.18)a

 

 - Intervention label denotes absolute amount (“Low-fat”)

2

167

SMD (IV, Random, 95% CI)

−0.09 (−0.28 to 0.11)a

 - Intervention label denotes relative amount (“Reduced-fat)

4

434

SMD (IV, Random, 95% CI)

0.03 (−0.19 to 0.26)a

Chi2 = 0.23, df = 2, P = 0.89

 - Female participants only

2

343

SMD (IV, Random, 95% CI)

0.09 (−0.12 to 0.30)a

 

 - Male and female participants

6

670

SMD (IV, Random, 95% CI)

−0.06 (−0.24 to 0.12)a

Chi2 = 1.10, df = 1, P = 0.30

 - Parallel group (between-subjects) design

4

301

SMD (IV, Random, 95% CI)

0.00 (−0.22 to 0.23)a

 

 - Crossover (within-subjects) design

4

712

SMD (IV, Random, 95% CI)

−0.03 (−0.23 to 0.17)a

Chi2 = 0.04, df = 1, P = 0.84

Understanding of label

3

155

SMD (IV, Random, 95% CI)

−0.57 (−0.89 to −0.26)a

Z = 3.57, P = 0.0004

  1. SMD standardised mean difference, IV generic inverse variance, random Random effects model, 95% CI 95% confidence interval, aSummary effect size (pooled estimate), N/A not applicable